Filing Details

Accession Number:
0001246360-15-001885
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-29 17:28:09
Reporting Period:
2015-04-27
Filing Date:
2015-04-29
Accepted Time:
2015-04-29 17:28:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
911326 Synageva Biopharma Corp GEVA Biological Products, (No Disgnostic Substances) (2836) 561808663
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532219 Anthony Quinn 33 Hayden Ave
Lexington MA 02421
Evp, Cmo & Head Of R&D No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-27 10,000 $1.70 15,637 No 4 M Direct
Common Stock Disposition 2015-04-27 10,000 $110.00 5,637 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-04-27 10,000 $0.00 10,000 $1.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,228 2021-05-25 No 4 M Direct
Footnotes
  1. The sale of shares of the Company's common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 6, 2015.
  2. The Stock Option granted the reporting person an option to purchase 47,228 shares of Common Stock (the "Shares"). 25% of the Shares vested and became exercisable on 05/25/2012, and 1/36 of the remainder of the Shares vest and become exercisable monthly thereafter.